Fig. 1From: Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancerThe timeline for selected patients from IRR group who underwent intervention due to incomplete radiological response 12 weeks after treatment completion and/or presented cfHPV16 DNA at that timeBack to article page